HHS Project NextGen to study novel COVID-19 vaccines, technologies
The Department of Health and Human Services’ Administration for Strategic Preparedness and Response recently awarded over $500 million to prepare for clinical trial three COVID-19 vaccine candidates that target better or longer-lasting immune response; increase central laboratory capacity for sample testing; and investigate better ways to develop monoclonal antibodies and evaluate and administer vaccines.
“By investing in next-generation vaccines and treatments, we can improve our ability to respond to new variants, reduce transmission, stop infections, and save lives,” said HHS Secretary Xavier Becerra.
Related News Articles
Headline
Fewer than one in four health care professionals working in acute care hospitals and nursing homes were up to date with COVID-19 vaccination during the 2022-23…
Headline
Children under age 12 should receive a 0.25 milliliter dose of the 2023-24 Moderna COVID-19 vaccine, not the full vial for that age group, the Food and Drug…
Headline
The Department of Health and Human Services Oct. 27 urged Merck and Pfizer to work with private insurers to maintain access to their COVID-19 oral antiviral…
News
To enjoy a healthy Thanksgiving with family and friends, get vaccinated against the flu and COVID-19. That’s the message of AHA’s latest United Against the Flu…
Headline
The Department of Health and Human Services in November will begin transitioning to commercial distribution an estimated 7.9 million treatment courses of the…
Chairperson's File
Once October starts, many of us think “autumn” and also “flu season.” Time to get a flu shot — and a COVID-19 and RSV vaccine too.
For the first time, health…